Catalyst
Slingshot members are tracking this event:
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of July 19, 2017, for romosozumab
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
AMGN | Community voting in process |
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 16, 2017
Occurred Source:
http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-newsArticle&ID=2286628
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Romosozumab, Pdufa Date, Osteoporosis